Aging Clinical and Experimental Research

, Volume 28, Issue 2, pp 207–214 | Cite as

Sixteen weeks of resistance training decrease plasma heat shock protein 72 (eHSP72) and increase muscle mass without affecting high sensitivity inflammatory markers’ levels in sarcopenic men

  • K. Perreault
  • A. Courchesne-Loyer
  • M. Fortier
  • M. Maltais
  • R. Barsalani
  • E. Riesco
  • Isabelle J. DionneEmail author
Original Article



Sarcopenia has been associated with increased systemic inflammation and risk of physical disability in older adults. Recently, extracellular heat shock protein 72 (eHSP72) was proposed as a biomarker of sarcopenia but its response to interventions designed to increase muscle mass has never been evaluated.


The present study was designed to (1) assess eHSP72 levels following resistance training and, (2) determine whether changes in eHSP72 correlate to changes in muscle mass and inflammatory markers.


A total of 26 sarcopenic men participated in a 16-week resistance training program. The following variables were measured pre–post-intervention: plasma HSP72, serum high sensitivity (hs) inflammatory markers: interleukin-6 (hsIL-6), C-reactive protein (hsCRP), and tumor necrosis factor alpha (hsTNF-α), lean body mass (LBM) and appendicular muscle mass index (appMMI).


eHSP72 was detected in 47 % of our participants and its level significantly decreased (P = 0.04) after the intervention, with a concomitant increase in several LBM variables and appMMI (all P < 0.035). Serum hsIL-6, hsCRP and hsTNF-α changes did not reach significance. Baseline hsIL-6 and hsCRP levels were negatively correlated with several LBM variables but solely baseline hsIL-6 was associated with changes in appLBM. No correlations were found between changes in measured variables.


Attenuation of eHSP72 following resistance training in parallel with increase in LBM variables showed a concordance between the evolution of this biomarker and a clinical outcome relevant to sarcopenia.


Nevertheless, the low bloodstream detection rate of eHSP72 in a sarcopenic otherwise healthy population might limit its use in clinical settings for now.


Heat shock protein (HSP) Resistance training Systemic inflammation Muscle mass Sarcopenia Elderly men 



The authors would like to thank Martine Fisch, Christine Rioux-Perreault, Johann Lebon, Daniel Mireault, Joanie Lévesque and all kinesiologists supervising the exercise training protocol for their professional assistance. We are also grateful to all men who participated in this study. The Dairy Farmers of Canada supported this study financially. Karine Perreault detains a master degree scholarship from the Centre de recherche sur le vieillissement du CSSS-IUGS. Isabelle J. Dionne holds a Canada Research Chair in Exercise recommendations in healthy aging.

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Human and Animal Rights

All procedures performed in this study were in accordance with the ethical standards of the Research Ethics Committee of the CSSS-IUGS and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Informed consent

All participants signed a written informed consent during the first visit to the Research Centre on Aging (Geriatric Institute of the University of Sherbrooke, CSSS-IUGS, Sherbrooke, QC, Canada).


  1. 1.
    Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S–991SPubMedGoogle Scholar
  2. 2.
    Visser M (2009) Towards a definition of sarcopenia—results from epidemiologic studies. J Nutr Health Aging 13:713–716CrossRefPubMedGoogle Scholar
  3. 3.
    Janssen I, Baumgartner RN, Ross R et al (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159:413–421CrossRefPubMedGoogle Scholar
  4. 4.
    Hunter GR, McCarthy JP, Bamman MM (2004) Effects of resistance training on older adults. Sports Med 34:329–348CrossRefPubMedGoogle Scholar
  5. 5.
    Fujita S, Volpi E (2006) Amino acids and muscle loss with aging. J Nutr 136(1 Suppl):277S–280SPubMedPubMedCentralGoogle Scholar
  6. 6.
    Koopman R (2011) Dietary protein and exercise training in ageing. Proc Nutr Soc 70:104–113CrossRefPubMedGoogle Scholar
  7. 7.
    American College of Sports Medicine, Thompson WR, Gordon NF et al (2010) ACSM’s guidelines for exercise testing and prescription. In: Chapter 4: Health-related physical fitness testing and interpretation, p 90, 8th edn. Wolters Kluwer, Philadelphia, pp xxi, p 380Google Scholar
  8. 8.
    Fry CS, Rasmussen BB (2011) Skeletal muscle protein balance and metabolism in the elderly. Curr Aging Sci 4(3):260–268CrossRefPubMedGoogle Scholar
  9. 9.
    Wieland HA, Michaelis M, Kirschbaum BJ et al (2005) Osteoarthritis—an untreatable disease? Nat Rev Drug Discovery 4:331–344. doi: 10.1038/nrd1693 CrossRefPubMedGoogle Scholar
  10. 10.
    Nedergaard A, Karsdal MA, Sun S et al (2013) Serological muscle loss biomarkers: an overview of current concepts and future possibilities. J Cachexia Sarcopenia Muscle 4:1–17CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Ogawa K, Kim HK, Shimizu T et al (2012) Plasma heat shock protein 72 as a biomarker of sarcopenia in elderly people. Cell Stress Chaperones 17:349–359CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Beyer I, Njemini R, Bautmans I et al (2012) Inflammation-related muscle weakness and fatigue in geriatric patients. Exp Gerontol 47:52–59CrossRefPubMedGoogle Scholar
  13. 13.
    Macario AJ, Conway de Macario E (2005) Sick chaperones, cellular stress, and disease. New Engl J Med 353:1489–1501CrossRefPubMedGoogle Scholar
  14. 14.
    Pockley AG (2002) Heat shock proteins, inflammation, and cardiovascular disease. Circulation 105:1012–1017CrossRefPubMedGoogle Scholar
  15. 15.
    Terry DF, Wyszynski DF, Nolan VG et al (2006) Serum heat shock protein 70 level as a biomarker of exceptional longevity. Mech Ageing Dev 127:862–868CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Ogawa K, Sanada K, Machida S et al (2010) Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women. Mediators Inflamm 2010:171023. doi: 10.1155/2010/171023 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Aleman H, Esparza J, Ramirez FA et al (2011) Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing 40:469–475CrossRefPubMedGoogle Scholar
  18. 18.
    Schaap LA, Pluijm SM, Deeg DJ et al (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119:526.e9–526.e17CrossRefGoogle Scholar
  19. 19.
    Washburn RA, Smith KW, Jette AM et al (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162CrossRefPubMedGoogle Scholar
  20. 20.
    Luhrmann PM, Herbert BM, Gaster C et al (1999) Validation of a self-administered 3-day estimated dietary record for use in the elderly. Eur J Nutr 38:235–240CrossRefPubMedGoogle Scholar
  21. 21.
    Beyer I, Bautmans I, Njemini R et al (2011) Effects on muscle performance of NSAID treatment with piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. A double blind randomized controlled trial. BMC Musculoskel Disord 12:292CrossRefGoogle Scholar
  22. 22.
    Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Sci Med Sci 56:M146–M156CrossRefGoogle Scholar
  23. 23.
    Chang SS, Weiss CO, Xue QL et al (2012) Association between inflammatory-related disease burden and frailty: results from the Women’s Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr 54:9–15CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Leng SX, Xue QL, Tian J et al (2007) Inflammation and frailty in older women. J Am Geriatr Soc 55(6):864–871CrossRefPubMedGoogle Scholar
  25. 25.
    Walston J, McBurnie MA, Newman A et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162:2333–2341CrossRefPubMedGoogle Scholar
  26. 26.
    Welc SS, Judge AR, Clanton TL (2013) Skeletal muscle interleukin-6 regulation in hyperthermia. Am J Physiol Cell Physiol 305(4):C406–C413CrossRefPubMedGoogle Scholar
  27. 27.
    Yamada P, Amorim F, Moseley P et al (2008) Heat shock protein 72 response to exercise in humans. Sports Med 38:715–733CrossRefPubMedGoogle Scholar
  28. 28.
    Fleshner M, Johnson JD (2005) Endogenous extra-cellular heat shock protein 72: releasing signal(s) and function. Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group 21:457–471CrossRefGoogle Scholar
  29. 29.
    Whitham M, Fortes MB (2008) Heat shock protein 72: release and biological significance during exercise. Front Biosci J Virtual Libr 13:1328–1339CrossRefGoogle Scholar
  30. 30.
    Morton JP, Kayani AC, McArdle A et al (2009) The exercise-induced stress response of skeletal muscle, with specific emphasis on humans. Sports Med 39:643–662CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • K. Perreault
    • 1
    • 2
  • A. Courchesne-Loyer
    • 2
    • 3
  • M. Fortier
    • 2
  • M. Maltais
    • 1
    • 2
  • R. Barsalani
    • 1
    • 2
  • E. Riesco
    • 1
    • 2
  • Isabelle J. Dionne
    • 1
    • 2
    Email author
  1. 1.Faculté des sciences de l’activité physiqueUniversité de SherbrookeSherbrookeCanada
  2. 2.Centre de recherche sur le vieillissement du CSSS-IUGSSherbrookeCanada
  3. 3.Faculté de médecine et des sciences de la santéUniversité de SherbrookeSherbrookeCanada

Personalised recommendations